11.33
5.58%
-0.67
Atara Biotherapeutics Inc (ATRA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
543.39%
27.36
|
4.252 | 2.138 | 0.957 | 1.226 |
Operating Expenses
|
8.74%
58.60
|
64.21 | 71.75 | 72.37 | 76.24 |
Interest Income/Expense |
1.96%
1.153
|
1.176 | 1.395 | 1.378 | 1.336 |
Benefits Costs and Expenses |
8.67%
59.09
|
64.69 | 71.95 | 72.06 | 75.97 |
Costs And Expenses |
8.74%
58.60
|
64.21 | 71.75 | 72.06 | 75.97 |
Depreciation and Amortization |
15.44%
1.391
|
1.205 | 1.209 | 1.201 | 1.214 |
Operating Income/Loss |
47.89%
-31.25
|
-59.96 | -69.61 | -71.41 | -75.02 |
Income/Loss From Continuing Operations Before Tax |
47.50%
-31.73
|
-60.44 | -69.82 | -71.11 | -74.75 |
Income Tax Expense/Benefit |
118.18%
0.024
|
0.011 | -0.019 | 0.001 | 0.022 |
Income/Loss From Continuing Operations After Tax |
47.47%
-31.75
|
-60.45 | -69.80 | -71.11 | -74.77 |
Net Income/Loss
|
47.47%
-31.75
|
-60.45 | -69.80 | -71.11 | -74.77 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
18,670%
140.59
|
0.749 | 106.40 | 105.09 | 103.97 |
Diluted Average Shares |
18,670%
140.59
|
0.749 | 106.40 | 105.09 | 103.97 |
Basic Earnings Per Share |
58.93%
-0.23
|
-0.56 | -0.66 | -0.68 | -0.72 |
Diluted Earnings Per Share |
58.93%
-0.23
|
-0.56 | -0.66 | -0.68 | -0.72 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):